< Back

PolyPid to Present at First World Association Against Infection in Orthopaedics and Trauma Congress

Aug 28, 2021

PETACH TIKVA, Israel, Aug. 17, 2021 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), a late-stage biopharma focusing on developing targeted, locally administered and prolonged-release therapeutics to improve surgical outcomes, announced today that its Co-Founder and Chief Scientific Officer Dr. Noam Emanuel, will deliver a virtual presentation at the first World Association against Infection in Orthopaedics and Trauma (WAIOT) Congress on August 28, 2021.

 

The virtual presentation will be a part of the Septic Non-Union and Bone Loss Management session. The presentation details can be found below:

Location: Room 3
Lecture Number: 0 41
Time: 16:11 – 16:16 CEST
Presentation Title:
    Improved Healing of Gustilo Type IIIA and IIIB Open Long Bone Fractures Treated with Local Biodegradable Prolonged Release Antibiotic Formulated Bone Graft During the First Surgical Intervention Post-Surgery: A Prospective, Randomized Clinical Trial
Presenter:
    Dr. Noam Emanuel, PolyPid

 

WAIOT is the first and the largest worldwide scientific association, focused on bone, joints, biofilms- and implant-related infections. The event will be attended by 1,700 members coming together virtually from 101 countries.